Decramer, Marc et al
"Once-daily QVA149 reduces exacerbations and improves health status in comparison with glycopyrronium and tiotropium in patients with severe-to-very severe COPD: The SPARK study." European Respiratory Journal
42.Suppl 57
(2013):
P756.
Web. 18 April. 2024.